To demonstrate the impact of VX-970 on cisplatin-induced ATR signaling and DNA repair, H2009 lung cancer cells were treated with VX-970 and cisplatin as single agents or in combination (Figure 1B). The gene discussed is ATR; the disease is lung carcinoma.